Recent FDA Approval of Danicopan for Patients with PNH
Dr. Caroline Piatek describes the purpose and use of this new drug approval for some patients with PNH, or Paroxysmal Nocturnal Hemoglobinuria.
Podcast Episodes
Our patients, families, and caregivers have been asking us for more ways to learn about rare blood cancers and bone marrow failure diseases. So, we're coming to you today, thanks to generous support from individual donors and our corporate partners.
Athletic Service Member Conquers Aplastic Anemia and MDS with Transplant
Damian was very active when routine blood work showed a problem. But Damian decided that going through treatment would be his mission, even if that meant two transplants. Listen here to his story.
Conquering PRCA: a conversation with Ron Duncan, Patient Survivor
Ron had a sudden alert when he learned he had one of the rarest of diseases. Listen to this conversation to learn how he managed diagnosis, treatment, and survivorship in this episode.
Hepatitis-Associated Aplastic Anemia with Dr. Roma Rajput
Find out the relationship between Hepatitis and Aplastic Anemia in this episode with Dr. Roma Rajput.
Brian Anderson Explains Life, Treatment, and Surviving MDS
AAMDSIF Director of Patient Programs, Leigh Clark, asks Brian about his life before diagnosis, during "watch and wait," through transplant, to now. Listen here to his myelodysplastic syndromes, or MDS, patient journey.
Conversation with patient, Mario Rivera: His Experience with Aplastic Anemia
AAMDSIF Director of Patient Services, Leigh Clark, asks Mario about his journey with Aplastic Anemia. The conversation includes treatment and survivorship.
Evan's Life is Turned Upside Down by Diagnosis of PNH
Evan biked daily. He had no symptoms. The diagnosis was fast, but surprising. Evan shares his remarkable story in this episode.
Approval of Fabhalta (iptacopan), Oral Medication for Patients with PNH
What does this FDA approval mean for patients with PNH? Find out how this oral medication, Fabhalta, could replace one of the infusion treatments in this interview with Dr. Bart Scott.
FDA approval of Tibsovo with Dr. Amir Fathi
Here is a discussion about recent FDA approval of Tibsovo for Relapsed/Refractory MDS with Dr. Amir Fathi, who is an Associate Professor of Medicine at Harvard Medical School and the Director of the Leukemia Program at Massachusetts General Hospital.
Expanded Access to Reblozyl® for Patients with Dr. Guillermo Garcia Manero
This episode focuses on the US Food and Drug Administration expanded access approval of luspatercept or Reblozyl with Dr. Guillermo Garcia-Manero, Chief of the Section of MDS in the Department of Leukemia at MD Anderson Cancer Center in Houston.
Patient Education Sponsors
Our Diamond Level Sponsors:
Our Gold Level Sponsors:
Our Bronze Level Sponsors:
Special thanks to Abbvie and Taiho Oncology